PWMG
FOLD

Private Wealth Management Group’s Amicus Therapeutics FOLD Stock Holding History

Private Wealth Management Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48K Hold
102
– – ﹤0.01% 1170
2025
Q4 		$1.45K Hold
102
– – ﹤0.01% 1177
2025
Q3 		$804 Hold
102
– – ﹤0.01% 1328
2025
Q2 		$585 Buy
+102
New +$658 ﹤0.01% 1396
2024
Q2 		– Sell
-84
Closed -$990 – 1545
2024
Q1 		$990 Hold
84
– – ﹤0.01% 1269
2023
Q4 		$1.19K Buy
+84
New +$954 ﹤0.01% 1198

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Private Wealth Management Group's FOLD Position: Q1 2026 in Review

Private Wealth Management Group held its Amicus Therapeutics (FOLD) position steady in Q1 2026 at 102 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1170.

Private Wealth Management Group first reported a position in FOLD in Q4 2023 and has held it in 6 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Private Wealth Management Group held 102 shares of Amicus Therapeutics worth $1.48K as of Q1 2026.
  • Private Wealth Management Group left its Amicus Therapeutics share count unchanged in Q1 2026.
  • Amicus Therapeutics made up ﹤0.01% of Private Wealth Management Group's portfolio in Q1 2026, its #1170 holding.
  • Private Wealth Management Group first reported a position in Amicus Therapeutics in Q4 2023 and has held it in 6 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Private Wealth Management Group's 13F filing for Q1 2026, filed 23 Apr 2026.